Well, we all knew SIRT did something. That's why SRX sold 50k doses of it over the past 10 years right?
The trouble is, anecdotal cases like these mean nothing for standard of care guidelines. And, this "binary" outcome risk is not something that every investor is comfortable with, even though the probability of success might be like 90%. That's why market cap is still $1.8bn when, if we are successful, we will easily do over $1bn in revenue on 85% margin
Remember the Russian cohort for the ACL trial? Anyone?
Dramatic response to SIRT, page-6
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.8¢ |
Change
-0.003(1.39%) |
Mkt cap ! $75.34M | |||
| Open | High | Low | Value | Volume |
| 17.8¢ | 17.8¢ | 17.5¢ | $8.638K | 48.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 11236354 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1327703 | 33 |
View Market Depth
| Last trade - 15.52pm 09/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |